SynthesisScientific reports2024

Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer's disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness.

Konstantinos I Avgerinos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.